Multiple Sclerosis & Neuro-Immunology
This session examines autoimmune-mediated central nervous system conditions, focusing primarily on multiple sclerosis and neuromyelitis optica. Topics include demyelination mechanisms, high-efficacy disease-modifying therapies, B-cell depletion strategies, and neuro-immunological biomarkers. Expert clinicians at Stroke 2027 will discuss real-world management of acute relapses, radiological isolated syndrome, and long-term neuroprotection. Participants will learn to navigate the shifting landscape of immune-targeted treatments, gaining actionable skills to customize therapeutic plans that reduce relapse frequencies.